Resultados de la búsqueda 101-110 of 7495 for sex therapy

1. Sequedad vaginal - Mayo Clinic

   Treating sexual problems in aging adults. In: The Wiley Handbook of Sex Therapy. John Wiley & Sons; 2017. Kingsberg SA, et al. Female sexual health ...

2. Dermatología - Ensayos clínicos - Mayo Clinic

   ... therapy per local standard of care (SoC), best ... Correlate results with other variables, such as patient age, sex ... treatment response to targeted ...

3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

4. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

5. Ensayos clínicos - Neurología

   ... sex-specific hormonal factors associated with onset of symptoms in MSA. ... therapeutic susceptibility or response to therapy. ... therapy protocols. A Study ...

6. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

7. Ensayos clínicos - Neurología

   ... sex-specific hormonal factors associated with onset of symptoms in MSA. ... therapeutic susceptibility or response to therapy. ... therapy protocols.

8. Ensayos clínicos - Neurología

   ... sex-specific hormonal factors associated with onset of symptoms in MSA. ... therapeutic susceptibility or response to therapy. ... therapy protocols. A Study ...

9. Ensayos clínicos - Neurología

   ... sex-specific hormonal factors associated with onset of symptoms in MSA. ... therapeutic susceptibility or response to therapy. ... therapy protocols. A Study ...

10. Cirugía - Ensayos clínicos - Mayo Clinic

    This project will investigate whether ctDNA analysis in newly diagnosed stage I, II, III breast cancer patients treated with neoadjuvant systemic therapy can ...